Dataset related to article: "Functional recovery in hip fracture patients: the role of pharmacotherapy"

We provide the raw data used for the following article: Gialanella B, Santoro R, Prometti P, Giordano A, Monguzzi V, Comini L, Olivares A, Grioni G.<br> <em>Functional recovery in hip fracture patients: the role of pharmacotherapy</em>.<br> "Aging Clin Exp Res." 2020 Jan;32(1):49-57.<br> doi: 10.1007/s40520-019-01175-w. Epub 2019 Mar 21. PMID: 30900212. <strong>Background and aim: </strong>The aim of this prospective observational cohort study was to verify the relationship between number of drugs used and functional outcome in hip fracture patients undergoing rehabilitation. <strong>Methods: </strong>This study was conducted on 139 patients with hip fracture who underwent a rehabilitation program. Efficiency rate in the Functional Independence Measure (FIM) and Berg Balance Scale (BBS), and length of stay (LOS) were the outcome measures. <strong>Results: </strong>At the end of rehabilitation, 66.1% of patients showed an increase in number of drugs used, while 33.9% used the same or lower number of drugs than at admission. At the end of rehabilitation patients with increased pharmacotherapy took a higher total number of drug classes (p = 0.001), had longer LOS (p = 0.009) and lower Berg efficiency (p = 0.048) than patients with the same or lower pharmacotherapy. The number of drugs used at discharge was an independent determinant of LOS (beta = 0.19, p = 0.022) and FIM efficiency (beta = - 0.20, p = 0.025). Age was a determinant of LOS (beta = 0.17, p = 0.044) and BBS efficiency (beta = - 0.23, p = 0.009), while CIRS severity was a determinant of BBS efficiency only (beta = - 0.22, p = 0.016). <strong>Discussion: </strong>Findings of study indicate that in hip fracture patients, the number of drugs prescribed at discharge is an important indicator of LOS and rehabilitation efficiency. <strong>Conclusions: </strong>These findings can help the physician to better plan the rehabilitation of hip fracture patients who require polypharmacy.